Drug intelligence / Profile preview

(1R)-menthyl hexyl phosphonate group

Development stage: Unknown
Modality: Small Molecules

Overview

(1R)-menthyl hexyl phosphonate group is a synthetic small molecule with the molecular formula C16H33O3P. It is classified as an experimental compound and has not been approved for clinical use in any country. The compound acts as a cholinesterase inhibitor, targeting cholinesterase enzymes to potentially modulate neurotransmitter breakdown. No approved indications or clinical trials have been reported for this molecule. Its structure features a menthyl moiety linked via an oxygen atom to a phosphonic acid functionalized with a hexyl chain[1][2].

Other names: (1R)-menthyl hexyl phosphonate grouphexyl-[(1R,2S,5R)-5-methyl-2-propan-2-ylcyclohexyl]oxyphosphinic acid

Targets

AcetylcholinesteraseButyrylcholinesterase

Beyond the preview

Go deeper on (1R)-menthyl hexyl phosphonate group.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on (1R)-menthyl hexyl phosphonate group.

Explore the full profile